Mike Hutton

Active 1996–2023

80
Papers
19,649
Citations
43
h-index
56
i10-index

Citations

Citations per year for Mike Hutton1991: 5 citations1996: 5 citations1997: 48 citations1998: 90 citations1999: 148 citations2000: 210 citations2001: 208 citations2002: 276 citations2003: 267 citations2004: 347 citations2005: 217 citations2006: 318 citations2007: 363 citations2008: 378 citations2009: 360 citations2010: 356 citations2011: 384 citations2012: 393 citations2013: 307 citations2014: 279 citations2015: 220 citations2016: 243 citations2017: 255 citations2018: 203 citations2019: 508 citations2020: 489 citations2021: 437 citations2022: 294 citations2023: 240 citations2024: 328 citations2025: 185 citations2026: 6 citations1992–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,282 citing papers, 36% of this breakdownUnited Kingdom: 890 citing papers, 9.8% of this breakdownGermany: 542 citing papers, 5.9% of this breakdownCanada: 503 citing papers, 5.5% of this breakdownJapan: 380 citing papers, 4.2% of this breakdownChina: 369 citing papers, 4% of this breakdownItaly: 319 citing papers, 3.5% of this breakdownFrance: 292 citing papers, 3.2% of this breakdownBelgium: 264 citing papers, 2.9% of this breakdownAustralia: 257 citing papers, 2.8% of this breakdownSpain: 223 citing papers, 2.4% of this breakdownSwitzerland: 200 citing papers, 2.2% of this breakdown
0%36%Other 17.6%

Fields

  • Medicine69.4%
  • Biochemistry, Genetics and Molecular Biology15.6%
  • Neuroscience6.9%
  • Engineering3.8%
  • Computer Science2.8%
  • Immunology and Microbiology0.4%
  • Other1.1%

Topics

  • Alzheimer's disease research and treatments19.7%
  • Amyotrophic Lateral Sclerosis Research6.4%
  • Parkinson's Disease Mechanisms and Treatments4.8%
  • Cholinesterase and Neurodegenerative Diseases4.4%
  • Prion Diseases and Protein Misfolding3.4%
  • Neuroinflammation and Neurodegeneration Mechanisms3.3%
  • Other58%

Coauthors

All papers

Open in search
  1. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lars Lannfelt, Michael Neystat, Stanley Fahn, Francis Dark, Tony Tannenberg, Peter R. Dodd, Nick Hayward, John B. Kwok, Peter R. Schofield, Athena Andreadis, Julie S. Snowden, David Craufurd, David Neary, F. Owen, Ben A. Oostra, John Hardy, Alison Goate, John C. van Swieten, David Mann, Timothy Lynch, Peter Heutink - Nature 1998 cited by 3,540

  2. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2006 cited by 2,121

  3. Understanding and Mitigating Hardware Failures in Deep Learning Training Systems

    Authors: , , , , , , - Symposium on Computer Architecture, ISCA 2023 cited by 47

  4. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

    Authors: , , , , , , , , , , , , , - Science 2001 cited by 1,602

  5. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2000 cited by 1,369

  6. Tauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles

    Authors: , , , , , , - Science 2001 cited by 953

  7. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2006 cited by 578

  8. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

    Authors: , , , , , , , , , , , , , , , , - Nature 1996 cited by 1,453

  9. Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice

    Authors: , , , , , , , , , , , , , , , , - Journal of Neuroscience 2010 cited by 575

  10. Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice

    Authors: , , , , , , , , , - American Journal Of Pathology 2007 cited by 271

  11. Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice

    Authors: , , , , , , , , , , , , , , , , , , , - Neuron 2005 cited by 558

  12. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rosa Rademakers - PLoS Genetics 2008 cited by 463

  13. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 1998 cited by 349

  14. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau

    Authors: , , , , - Nature Neuroscience 1998 cited by 344

  15. Improving Awareness Could Transform Outcomes in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 1]

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Global Spine Journal 2022 cited by 50

  16. Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

    Authors: , , , , , , , , , , , , , , - Journal of Neuroscience 2007 cited by 487

  17. 5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10

    Authors: , , , , , , , , - Journal of Biological Chemistry 1999 cited by 299

  18. Argyrophilic Grain Disease Is a Sporadic 4-Repeat Tauopathy

    Authors: , , , , , , , , - Journal of Neuropathology & Experimental Neurology 2002 cited by 271

  19. Developing Therapeutic Approaches to Tau, Selected Kinases, and Related Neuronal Protein Targets

    Authors: , , , - Cold Spring Harbor Perspectives in Medicine 2011 cited by 125

  20. Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations

    Authors: , , , , , , , , - FEBS Letters 1999 cited by 289

  21. Prominent phenotypic variability associated with mutations in Progranulin

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neurobiology of Aging 2007 cited by 182

  22. Matrix metalloproteinases in arthritic disease.

    Authors: , , , , , , , - Arthritis Research 2002 cited by 306

  23. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Neary, Gerard D Schellenberg, Thomas G. Beach, Marsel Mesulam, David Mann, Jordan Grafman, Ian R. Mackenzie, Howard Feldman, Thomas D. Bird, Ron Petersen, David S. Knopman, Bradley F. Boeve, Dan Geschwind, Bruce L. Miller, Zbigniew K. Wszołek, Carol F. Lippa, Eileen H. Bigio, Dennis W. Dickson, Neill R. Graff‐Radford, Mike Hutton - The Lancet Neurology 2007 cited by 218

  24. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's Disease: linkage of poorer cognitive performance to tau pathology in forebrain

    Authors: , , , , , , - Brain Research 2004 cited by 125